Abstrak/Abstract |
Ameloblastoma, a local invasive odontogenic benign tumor, has a high rate of recurrence in the long term. The present research is a retrospective study of patients with mandible ameloblastoma after receiving mandibulectomy. The aim of this research is to evaluate the recurrence of ameloblastoma after mandibulectomy within 1–5 years.
Twenty-eight patients who had been treated with mandibulectomy with 1–1.5 cm safety margins to the healthy tissue in 2010–2015 were recalled for physical examination and panoramic X-ray. Surgery data, including patient age, gender, size of ameloblastoma, type of ameloblastoma, type of mandible resection, and type of reconstruction, were obtained from surgery reports and medical records. Suspected recurrence was diagnosed through incisional biopsy and confirmed by histological check-up.
Among the 28 patients included in this research, only one case of acanthomatous ameloblastoma showed recurrence in the soft tissue. No recurrence involving bones was observed. Mandibulectomy of ameloblastoma with 1–1.5 cm extension to the healthy bone is adequate to manage ameloblastoma. However, surgeons must pay attention to the safety margin during soft tissue excision, especially in the case of aggressive acanthomatous ameloblastoma. |